Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients.

Cancer medicine - 1 Aug 2021

Kefayat Amirhosein, Amouheidari Alireza, Ghahremani Fatemeh, Alirezaei Zahra

Abstract excerpt

BACKGROUND: Investigation of novel blood-circulating agents as potential biomarkers for glioblastoma multiforme (GBM) patients' diagnosis and monitoring has gained lots of attention, due to limitations of imaging modalities and invasive tissue biopsy procedures. The present study aims to assess the diagnostic and prognostic values of preoperative stem cell factor (SCF) plasma level in GBM patients. METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Modification Methylases
Share to DNA Repair Enzymes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Methylation

Share to Progression-Free Survival

Share to ROC Curve

Share to Stem Cell Factor

Share to Tumor Burden

Source

Open in PubMed Open full text

Identifiers

PMID: 34250760
DOI: 10.1002/cam4.4073
PMCID: PMC8335833

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients.PMID 34250760Read ↗

Stem Cell Utilization for Potential Reduction in Glioblastoma Multiforme (GBM): A Focused Narrative ReviewSemantic proximity Read ↗

Advances in stem cell-based therapeutic transfers for glioblastoma treatmentSemantic proximity Read ↗

Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?Semantic proximity Read ↗

Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme PatientsSemantic proximity Read ↗

Targeting Glioblastoma Stem Cells: Cell Surface MarkersSemantic proximity Read ↗

Cancer stem cell-vascular endothelial cell interactions in glioblastoma.Semantic proximity Read ↗

GCSF, A Diagnostic Marker and Potential Drug Target Candidate in GlioblastomaSemantic proximity Read ↗

The Diagnostic Value of Preoperative Hematology Makers in the Classification and Molecular Subtypes of Newly Diagnosed High-Grade GliomasSemantic proximity Read ↗

Towards developing biomarkers for glioblastoma multiforme: a proteomics viewSemantic proximity Read ↗

Potential diagnostic and drug target markers in glioblastomaSemantic proximity Read ↗

Plasmatic circRNA Predicting the Occurrence of Human GlioblastomaSemantic proximity Read ↗

Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.